Tag: IPO
LanzaTech on the road for up to $80 million in new investment
Tweet In New Zealand, LanzaTech is on the hunt for new investors to put in between $60 million and $80 million this year while holding off on an IPO until a first plant is up and running, probably around 2015. The two plants under construction are for 10 million and 25 gallons each, both based [...]
BioAmber completes IPO
Tweet Raises $80M at $10 per share; becomes first new industrial biotech company to complete IPO in more than a year. What went right and how? Is the IPO window re-opening? In Minnesota, BioAmber announced the pricing of its initial public offering of 8 million units consisting of one share of common stock and one [...]
Attention biotech shoppers: Save 31% on BioAmber’s IPO
Tweet Will BioAmber complete its IPO? As the industry waits, fingers crossed, the biosuccinic developer sweetens the pot with warrants, lower share prices. In Canada, BioAmber has reduced the proposed price range for its IPO to $10-$12 per share, down from a $15-$17 range — as it seeks to keep the initial public offering on [...]
BioAmber sets price range for $128M IPO
Tweet 8 million share offering at $15-$17 aims to raise $128 million. “We are selling 8,000,000 shares of common stock,” begins BioAmber’s latest SEC update, written in IPO-legalese. “The initial public offering price of our common stock is expected to be between $15.00 and $17.00 per share, which is the equivalent of €11.48 and €13.01 [...]
Mascoma withdraws its biofuels IPO
Tweet In New Hampshire, Mascoma Corporation applied to the SEC for the withdrawal of its S-1 Registration Statement, thereby abandoning its contemplated IPO. “The Company has determined at this time not to proceed with the offering due to market conditions,” the SEC notice said, and noted that “The Company may undertake a subsequent private offering. [...]
46% expect to see biofuels IPOs in the next 12 months
Tweet Biofuels Industry Survey Results: Key findings ahead of the World Biofuels Markets Congress & Exhibition In a recent survey conducted with bioenergy leading industry experts ahead of the 8th annual World Biofuels Markets Congress & Exhibition, 51% of those who responded rated their government’s policy as supportive, while 15% rated them as very supportive. [...]
Wall Street Journal article comments on negative market for cleantech
Tweet In the Wall Street Journal, an article focused on the alternative energy market noted the downturn of Amyris’s stock after its IPO in 2010, decliing over 80% in two years. The article discussed the higher profit margins accessible by oil refiners after the introduction of new drilling techniques in conjunction with the increasingly tough [...]
The Top 10 financing paths for biofuels, 2012-13
Tweet Dozens of deals – what are the hottest paths to $$$? Who’s forming capital in bioenergy this year, and when, where, why and how? In the old days, the process seemed simple: seed round to fund some lab work at the bench level, series A for proof of concept, series B for the pilot, [...]
Coskata switches focus from biomass to natural gas; to raise $100M in natgas-oriented private placement
Tweet Coskata, looking at CAPEX opportunities, political uncertainty, and the investor climate — switches to an “all natural gas” feedstock strategy. Initiates a $100M private placement, puts Alabama project on hold. In today’s Digest, we look at the rationale, the impact and the way forward. “In North America there’s a golden opportunity,” Coskata CEO Bill [...]
Are IPOs good for early-stage companies and advanced biofuels?
Tweet $104 million Elevance private financing round larger than last two IPOs; puts IPOs in focus; do the benefits outweigh the costs? Do advanced biofuels companies really need to be “thinking IPO”, industry leaders were asking this week after Elevance Renewable Sciences announced that it has raised $104 million in its Series E financing round. [...]
